CoverageForm 410-K10-Q8-K13D13G13F

ATNM Actinium Pharmaceuticals, Inc. - 8-K/A

Filed Mar 26, 2026. See issuer overview · financials · original on SEC.gov ↗
Accession
0001213900-26-034807
5.07

Item 5.07 - Submission of Matters to a Vote of Security Holders

113 words

Item 5.07
Submission of Matters to a Vote of Security Holders

As previously
reported in the Original Form 8-K, in an advisory vote held at the Annual Meeting on the frequency of future Say-on-Pay Votes, the Company’s
shareholders expressed their preference for a Say-on-Pay Vote to be conducted every year. On March 20, 2026, the Company’s board
of directors considered the outcome of this advisory vote and determined that future Say-on-Pay Votes will be conducted every year. The
Company’s board of directors will re-evaluate this determination after the next shareholder advisory vote on the frequency of Say-on-Pay
Votes (which will be at the 2031 Annual General Meeting of Shareholders, unless presented earlier).

1